Medical device company Procyrion, Inc. announced on Monday that it has named Lucas Buchanan as a new director.
Buchanan, a MedTech executive and experienced board member, is presently the chief operating officer and chief financial officer at Silk Road Medical. He has served in investment and commercial roles at The Vertical Group, Impax Laboratories, Medtronic and Ernst & Young. Currently, he serves on the board of directors for Endologix and as a strategic advisory board member of CRG LP.
Gary F Burbach, chair of the board of directors, Procyrion, said, 'We are thrilled to have an accomplished leader like Lucas join the Procyrion Board. Lucas' deep industry experience will be an important asset to the board and company as we work together to make the groundbreaking Aortix therapy available for patients with acute decompensated heart failure.'
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business
Insmed receives highest ranking in Science's 2024 Top Employers Survey
OncoZenge partners with Pharmanovia for exclusive BupiZenge commercialization in EMENA regions
Viatris added to Forbes' World's Best Employers 2024 list
Rarity Health named finalist for 21st MM+M Rare Disease Agency of the Year